Astilbin inhibits proliferation of rat aortic smooth muscle cells induced by angiotensin II and down-regulates expression of protooncogene

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 2, 2012, Pages 181-185

  Li, Ping ^a   Gao, Sihai ^a   Jie, Wei ^b   Ao, Qilin ^b   Huang, Yafei ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiotensin II; Astilbin; NF B; Proliferation; Protooncogene; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; ASTILBIN; FLAVONOL DERIVATIVE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN;

ANIMAL; AORTA; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RAT; SMOOTH MUSCLE FIBER; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; AORTA; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FLAVONOLS; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR;

EID: 84861132659     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-0032-8     Document Type: Article

References (17)

1. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation, 2008, 117(16):2131-2141 (Pubitemid 351596195)
2. Martínez-Dolz L, Almenar L, Reganon E, et al. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy. J Heart Lung Transplant, 2008, 27(7):760-766
3. Yan R, Xu Q. Astilbin selectively facilitates the apoptosis of interleukin-2-dependent phytohemagglutinin-activated jurkat cells. Pharmacol Res, 2001, 44(2):135-139 (Pubitemid 32695093)
4. Gao SH, Li P, Pan TC, et al. Astilbin induces apoptosis of activated T cells of mouse heart transplantation model with acute rejection in vitro. Chin J Exp Surg (Chinese), 2004, 21(4): 502
5. Han LK, Ninomiya H, Tangiguchi M, et al. Norepinephrine- augmenting lipolytic effectors from Astilbe thunbergii rhizomes. J Nat Prod, 1998, 61(8):1006-1011 (Pubitemid 28417259)
6. Gao SH, Pan TC. Protective effects of Astilbin on rat isolated heart reperfusion injury. Chin J Pract Chin Mod Med (Chinese), 2003, 3(16):1693-1694
7. Zhao J, Li P, Zhang Y, et al. The inhibitory effect of Astilbin on the arteriosclerosis of murine thoracic aorta transplantat. J Huazhong Univ Sci Technolog [Med Sci], 2009, 29(2):212-214
8. Moien-Afshari F, McManus BM, Laher I. Immunosuppression and transplant vascular disease: benefits and adverse effects. Pharmacol Ther, 2003, 100(2):141-156 (Pubitemid 37377910)
9. Gao SH, Chen T, Pan TC. Effect of Astilbin on expression of Bax, Bcl-2 and caspase-3 in allograft reactive T cells. Chin J Pract Chin Mod Med (Chinese), 2003, 3(16): 2110-2111
10. Gao SH, Li P, Pan TC. Effect of astilbin on expression of Fas, FasL, TNF-R1 and TNF-R2 in allograft reactive T cells. Chin J Pract Chin Mod Med (Chinese), 2004, 4(17): 217-218
11. Cai Y, Chen T, Xu Q, et al. Astilbin suppresses collagen- induced arthritis via the dysfunction of lymphocytes. Inflamm Res, 2003, 52(8):334-340 (Pubitemid 36995158)
12. Cai Y, Chen T, Xu Q, et al. Astilbin suppresses delayed- type hypersensitivity by inhibiting lymphocyte migration. J Pharm Pharmacol, 2003, 55(5):691-696 (Pubitemid 36705581)
13. Robbiani DF, Bothmer A, Callen E, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell, 2008, 135(6):1028-1038
14. Kumar N, Patowary A, Sivasubbu S, et al. Silencing c-MYC expression by targeting quadruplex in P1 promoter using locked nucleic acid trap. Biochemistry, 2008, 47(50):13179-88
15. Nahmias C, Strosberg D. The angiotensin AT recep tor: searching for signal transduction pathways and physiological function. Trends Pharmacol Sci, 1995, 16:223-225
16. Cotterman R, Jin VX, Krig SR, et al. SN-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res, 2008, 68(23):9654-9662
17. Kang OH, Jang HJ, Chae HS, et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res, 2009, 59(5):330-337